Carbidopa and Levodopa Tablets — Class II drug recall D-0998-2020
Terminated recall by Mayne Pharma Inc, reported 2020-03-18, distributed nationwide. Product Mix-Up: A foreign tablet was found in bottle.
| Recall number | D-0998-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mayne Pharma Inc, Greenville, NC, United States |
| Recall initiated | 2020-03-02 |
| Classified | 2020-03-09 |
| Reported by FDA | 2020-03-18 |
| Terminated | 2021-10-28 |
| Distributed | Nationwide (US) |
| NDC | 51862-0858-01 |
| Lot numbers | FG11514 |
| Expiration dates | 2021-05 |
Product
Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01
Reason for recall
Product Mix-Up: A foreign tablet was found in bottle.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0998-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.